On this day in 2023, Pinehill Hospital in Hitchin marked a major medical milestone with the launch of a pioneering treatment for men suffering from benign enlarged prostate.
The hospital became one of the first in the region to offer Aquablation therapy, an advanced robotic procedure that uses a heat-free waterjet combined with real-time imaging to remove excess prostate tissue. The technique aims to deliver effective relief from urinary symptoms while reducing common side effects associated with traditional surgery, such as incontinence and erectile dysfunction.
Benign Prostatic Hyperplasia (BPH) is a common condition, affecting an estimated one in two men aged 51 to 60. Studies show that 99 percent of men with BPH report a negative impact on their quality of life.
At the time of the launch, Professor Nikhil Vasdev, consultant urological and robotic surgeon at Pinehill Hospital, described Aquablation as a “game changer.” He explained:
“The use of robotic technology improves the precision of benign prostate surgery whilst significantly reducing the risk to sexual function and continence.”
Hospital director Duncan Barton emphasized the hospital’s commitment to patient care, saying:
“We are proud and delighted to be able to offer this new minimally invasive robotic surgery to our patients. Supporting our local community for their healthcare requirements is of absolute importance to us, as recognised in our company ethos of ‘people caring for people’.”
The introduction of Aquablation therapy at Pinehill Hospital signaled a step forward in improving treatment outcomes for men with enlarged prostates, combining innovation with a patient-centered approach.
YOU MAY ALSO LIKE
ProVerum Secures $80M to Advance Stent for Enlarged Prostate
